136 related articles for article (PubMed ID: 12931435)
1. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
[TBL] [Abstract][Full Text] [Related]
2. [Changes in serum levels of IGF-I and its binding proteins and their relation to microcirculation in obese patients].
Krsek M; Prázný M; Sucharda P; Marek J; Justová V; Lacinová Z
Vnitr Lek; 2001 Dec; 47(12):847-51. PubMed ID: 11826548
[TBL] [Abstract][Full Text] [Related]
3. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
Kasalová Z; Prázný M; Skrha J
Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
[TBL] [Abstract][Full Text] [Related]
4. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z
Cas Lek Cesk; 2001 Apr; 140(8):234-7. PubMed ID: 11392040
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the IGF-I system and its binding proteins and microvascular reactivity in Type 1 diabetes mellitus.
Krsek M; Prázný M; Skrha J; Justová V; Lacinová Z; Haas T
Physiol Res; 2002; 51(4):379-85. PubMed ID: 12449436
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W
Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
[TBL] [Abstract][Full Text] [Related]
7. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
Peczyńska J; Urban M; Głowińska B; Urban B
Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
[TBL] [Abstract][Full Text] [Related]
8. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
Brausewetter F; Jehle PM; Jung MF; Boehm BO; Brueckel J; Hombach V; Osterhues HH
Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
[TBL] [Abstract][Full Text] [Related]
9. [Changes in IGF-I levels and its binding proteins in diabetes mellitus and obesity].
Krsek M; Skrha J; Sucharda P; Justová V; Lacinová Z
Cas Lek Cesk; 2003; 142(4):216-9. PubMed ID: 12841123
[TBL] [Abstract][Full Text] [Related]
10. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
Akturk M; Arslan M; Altinova A; Ozdemir A; Ersoy R; Yetkin I; Ayvali E; Gonen S; Toruner F
Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
[TBL] [Abstract][Full Text] [Related]
11. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
Skrha J; Prázný M; Kvasnicka J; Kalvodová B
Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
[TBL] [Abstract][Full Text] [Related]
12. Microvascular Reactivity and Endothelial Function in Type 2 Diabetic Patients with Hyperlipidemia Treated with Simvastatin: 3-year Follow-up.
Prázný M; Kasalová Z; Mazoch J; Kvasnicka J; Skrha J
Prague Med Rep; 2009; 110(4):290-300. PubMed ID: 20059881
[TBL] [Abstract][Full Text] [Related]
13. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.
Krsek M; Prázný M; Marek J; Skrha J; Justová V; Lacinová Z
Growth Horm IGF Res; 2002 Feb; 12(1):54-9. PubMed ID: 12127302
[TBL] [Abstract][Full Text] [Related]
16. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
18. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
19. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
20. Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum.
Loukovaara M; Leinonen P; Teramo K; Nurminen E; Andersson S; Rutanen EM
Diabet Med; 2005 Apr; 22(4):434-9. PubMed ID: 15787669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
